Comparative Pharmacology
Head-to-head clinical analysis: M V I PEDIATRIC versus M V I 12 ADULT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: M V I PEDIATRIC versus M V I 12 ADULT.
M.V.I. PEDIATRIC vs M.V.I.-12 ADULT
Head-to-head clinical comparison of therapeutic indices and safety profiles.
Multivitamin preparation providing essential vitamins (A, C, D, E, K, B1, B2, B3, B5, B6, B7, B9, B12) as cofactors for enzymatic reactions, antioxidant functions, and maintenance of normal metabolic processes.
M.V.I.-12 Adult is a multivitamin combination that supplies essential vitamins (A, D, E, C, B1, B2, B3, B5, B6, B12, folic acid, biotin) to maintain normal metabolic functions, act as cofactors in enzymatic reactions, and support cellular respiration, antioxidant defense, and erythropoiesis.
FDA-approved: prevention and treatment of vitamin deficiencies in pediatric patients requiring parenteral nutrition.
FDA-approved for intravenous administration to prevent or treat vitamin deficiencies in patients requiring parenteral nutritionOff-label: adjunct in severe malnutrition, alcoholism, malabsorption syndromes, and during hemodialysis
Intravenous infusion: 5 mL (1 vial) added to appropriate IV fluid, administered over 30 minutes daily.
10 mL (one vial) added to 500 mL of IV fluid, infused over 8-24 hours once daily.
None Documented
None Documented
Variable; vitamin A: 9-25 days (stored in liver), vitamin D: 2-3 weeks (fat-soluble), vitamin C: 10-20 hours (renal function dependent), B-complex: 1-10 hours. Clinical context: accumulation risk in renal impairment.
Variable by component: e.g., thiamine 9-18 days (tissue stores), vitamin C 10-20 days (depletion), vitamin A 50-100 days (liver stores). Clinical context: half-lives reflect slow depletion; daily dosing maintains plasma levels.
Vitamins are metabolized via various pathways: water-soluble vitamins (B complex, C) are primarily metabolized in the liver and excreted renally; fat-soluble vitamins (A, D, E, K) are stored in adipose tissue and liver, metabolized via hepatic enzymes, and excreted in bile/feces.
Vitamins are metabolized via various pathways: water-soluble vitamins (B-complex, C) are minimally metabolized and excreted renally; fat-soluble vitamins (A, D, E) are stored in tissues and hepatically metabolized; folic acid is reduced to tetrahydrofolate by dihydrofolate reductase.
Renal: 60-80% (free vitamins), Biliary/fecal: 10-20% (unabsorbed and metabolites).
Renal: water-soluble vitamins (B-complex, C) excreted in urine; fat-soluble vitamins (A, D, E, K) undergo biliary/fecal excretion. Specific percentages vary per component; e.g., vitamin C ~50% renal, thiamine ~30-70% renal as metabolites.
Vitamin A: 90% (retinol-binding protein); Vitamin D: 85-90% (vitamin D-binding protein); Vitamin E: 90% (lipoproteins); Vitamin K: 99% (lipoproteins); B12: 90% (transcobalamins); other B vitamins: minimal to moderate (10-30%).
Vitamin A: 100% (retinol-binding protein, albumin). Vitamin D: 85-90% (vitamin D-binding protein). Vitamin E: ~90% (lipoproteins). Vitamin K: ~99% (lipoproteins). B-complex: low binding (<5-30%). Vitamin C: 24% (albumin).
0.5-1.0 L/kg for water-soluble; 1.5-3.0 L/kg for fat-soluble (due to tissue storage). Clinical meaning: extensive tissue distribution, especially liver for fat-soluble vitamins.
Variable: water-soluble vitamins confined to extracellular fluid (0.2-0.3 L/kg); fat-soluble vitamins larger due to adipose storage (e.g., vitamin D ~1.5 L/kg). Overall mean ~0.5 L/kg reflecting mixed distribution.
IV: 100% (only route); other routes not recommended (IM or SC may cause tissue damage or unpredictable absorption with fat-soluble vitamins).
Intravenous: 100%. Oral: not applicable; formulation is for IV use only. If extrapolated from oral vitamin absorption: variable (e.g., thiamine 5-10%, vitamin C 70-90%).
No specific dose adjustment required; however, caution in severe renal impairment due to potential accumulation of vitamins.
No dose adjustment required for renal impairment.
No specific dose adjustment required; monitor for vitamin A toxicity in Child-Pugh Class B/C.
No specific adjustment; use caution in severe hepatic impairment.
Children 11 years and younger: 5 mL (1 vial) intravenously daily. For infants <1 year, use M.V.I. Pediatric only per manufacturer guidelines.
Children 11 years and older: same as adult. Children under 11: 5 mL (one-half vial) daily.
No specific dose adjustment; monitor renal function and vitamin levels with prolonged use.
No specific adjustment; monitor for toxicity in elderly due to potential multivitamin accumulation.
Not applicable.
None
["Contains vitamin K; caution in patients on anticoagulants (may antagonize warfarin).","Contains aluminum; may accumulate with prolonged use in renal impairment.","Risk of allergic reactions including anaphylaxis (especially with vitamin B1/thiamine).","Monitor liver function due to potential hepatotoxicity with high doses of vitamin A.","Do not exceed recommended doses to avoid toxicity (especially fat-soluble vitamins)."]
["Allergic reactions including anaphylaxis may occur, especially in patients with hypersensitivity to any component","Do not exceed recommended dosage; vitamin A and D toxicity with prolonged high doses","Use with caution in patients with renal impairment or hypervitaminosis","May cause phlebitis or thrombophlebitis if infused rapidly"]
["Hypersensitivity to any component.","Pre-existing hypervitaminosis (e.g., vitamin A, D).","Severe renal impairment with inability to excrete aluminum."]
["Known hypersensitivity to any component","Pre-existing hypervitaminosis A or D","Severe folate deficiency with untreated pernicious anemia (due to B12 content)","Wilson's disease (due to copper content in some formulations)"]
Data Pending Review
Data Pending Review
No specific food interactions due to intravenous administration. However, patients receiving TPN should follow dietary restrictions as advised by their healthcare team to avoid metabolic imbalances.
No specific food interactions for intravenous administration. However, if transitioning to oral nutrition, consider that this product contains fat-soluble vitamins (A, D, E, K) which require dietary fat for absorption. Avoid excessive intake of vitamin K-rich foods (e.g., leafy greens) if on warfarin.
M.V.I. PEDIATRIC contains vitamins and minerals at recommended daily allowances. Vitamin A (retinol) at doses below 10,000 IU/day is not associated with increased teratogenic risk; however, high doses (>10,000 IU/day) are teratogenic. The product's vitamin A content (2300 IU per 5 mL) is below the teratogenic threshold. No known teratogenic effects from other components at physiological doses. For all trimesters, use is considered safe when administered according to recommended doses.
M.V.I.-12 ADULT is a multivitamin preparation. At recommended doses, no increased risk of congenital anomalies has been reported. However, high doses of vitamin A (retinol) can be teratogenic; this product contains retinol 3300 IU, which is below the teratogenic threshold (<10,000 IU/day). Use during pregnancy is generally considered safe when following recommended intakes.
Compatible with breastfeeding. Vitamins and minerals in M.V.I. PEDIATRIC are natural constituents of human milk. M/P ratios not established for the multi-vitamin mixture; individual vitamins transfer minimally. No adverse effects reported in nursed infants.
The vitamins in M.V.I.-12 ADULT are normally present in breast milk and are considered compatible with breastfeeding at recommended doses. No specific M/P ratios are available for the combination product; individual vitamins have variable transfer. Caution with vitamin A doses exceeding 10,000 IU/day.
No dose adjustment required. Pregnancy may increase requirements for certain vitamins (e.g., folic acid, iron), but M.V.I. PEDIATRIC is dosed per pediatric recommendations; for pregnant women, use should follow prenatal vitamin dosing guidelines. No pharmacokinetic changes necessitate dose adjustments for this product.
Pharmacokinetic changes in pregnancy (e.g., increased plasma volume, renal clearance) may require increased intake of water-soluble vitamins. However, for M.V.I.-12 ADULT (a multivitamin for injection), standard dosing is typically appropriate. No specific dose adjustment recommendations are established; use as directed for supplementation to meet increased demands.
Category C
Category C
M.V.I. PEDIATRIC is a multivitamin formulation for intravenous use in children. Ensure compatibility with TPN solutions; protect from light to prevent degradation. Monitor for allergic reactions, especially in patients with sensitivities to vitamins. Do not exceed recommended infusion rates to avoid adverse effects. Contains vitamin K; caution in patients on warfarin therapy.
M.V.I.-12 ADULT is a multivitamin formulation for intravenous use, indicated when oral nutrition is not feasible. Contains vitamins A, D, E, K, B1, B2, B3, B5, B6, B12, C, and biotin. Use with caution in patients with renal impairment due to potential accumulation of vitamin A and D. Do not administer intramuscularly or as a bolus; infuse over at least 30 minutes. Requires protection from light during storage and administration. Vitamin K content may antagonize warfarin therapy.
This medication provides essential vitamins when you cannot eat or drink enough.It is given intravenously, typically as part of total parenteral nutrition.Notify the healthcare provider if you experience any signs of allergic reaction such as rash, itching, or trouble breathing.Your doctor will monitor your vitamin levels and overall health during treatment.Inform your doctor about any other medications you are taking, especially blood thinners.
This medication is given as an intravenous infusion, not a shot or by mouth.Inform your healthcare provider if you are on blood thinners like warfarin, as this product contains vitamin K.Report any signs of allergic reaction, such as rash, itching, or difficulty breathing.You may experience mild irritation at the infusion site; let your nurse know if it becomes painful or red.Do not take extra vitamin supplements unless directed by your doctor.